| Ms Kimberley Shenee Player, MSN, APRN, FNP-C | |
|
8604 Greenville Ave Ste 103a, Dallas, TX 75243-7148 | |
| (214) 702-5855 | |
| Not Available |
| Full Name | Ms Kimberley Shenee Player |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner |
| Experience | 11 Years |
| Location | 8604 Greenville Ave Ste 103a, Dallas, Texas |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1003062928 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363LF0000X | Nurse Practitioner - Family | AP124059 (Texas) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Solar Health, P.a. | 3577625524 | 24 |
News Archive
Today Ingenuity Systems and CLC bio announced that they're collaborating to provide interoperability between their software solutions. The aim of the partnership is to provide researchers with the ability to easily exchange data between CLC bio's enterprise and desktop solutions and Ingenuity's pathway analysis software (IPA®), in order to perform both array and next-generation sequencing data and knowledge analyses.
Kaiser Health News provides a fresh take on health policy developments with "To The Moon" by Bob Englehart.
Professor and director of the WHO Collaborating Centre for Obesity Prevention at Deakin University in Australia, examines how "rich countries, ... particularly the U.S. and European Union but also Australia, Canada and New Zealand, ... are joining forces with tobacco, food, alcohol and pharmaceutical corporations to water down commitments that might flow from" this month's U.N. High-level Meeting on Non-Communicable Diseases (NCDs) in New York.
Shire plc, the global specialty biopharmaceutical company, today announced new findings on once-daily INTUNIV (guanfacine) Extended Release Tablets, the first selective alpha-2A agonist approved for the treatment of Attention Deficit Hyperactivity Disorder, at a major psychiatric meeting.
› Verified 9 days ago
| Entity Name | Solar Health, P.a. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1376724948 PECOS PAC ID: 3577625524 Enrollment ID: O20081229000479 |
News Archive
Today Ingenuity Systems and CLC bio announced that they're collaborating to provide interoperability between their software solutions. The aim of the partnership is to provide researchers with the ability to easily exchange data between CLC bio's enterprise and desktop solutions and Ingenuity's pathway analysis software (IPA®), in order to perform both array and next-generation sequencing data and knowledge analyses.
Kaiser Health News provides a fresh take on health policy developments with "To The Moon" by Bob Englehart.
Professor and director of the WHO Collaborating Centre for Obesity Prevention at Deakin University in Australia, examines how "rich countries, ... particularly the U.S. and European Union but also Australia, Canada and New Zealand, ... are joining forces with tobacco, food, alcohol and pharmaceutical corporations to water down commitments that might flow from" this month's U.N. High-level Meeting on Non-Communicable Diseases (NCDs) in New York.
Shire plc, the global specialty biopharmaceutical company, today announced new findings on once-daily INTUNIV (guanfacine) Extended Release Tablets, the first selective alpha-2A agonist approved for the treatment of Attention Deficit Hyperactivity Disorder, at a major psychiatric meeting.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Ms Kimberley Shenee Player, MSN, APRN, FNP-C 4730 N Habana Ave, Ste 204, Tampa, FL 33614-7163 Ph: (813) 549-2134 | Ms Kimberley Shenee Player, MSN, APRN, FNP-C 8604 Greenville Ave Ste 103a, Dallas, TX 75243-7148 Ph: (214) 702-5855 |
News Archive
Today Ingenuity Systems and CLC bio announced that they're collaborating to provide interoperability between their software solutions. The aim of the partnership is to provide researchers with the ability to easily exchange data between CLC bio's enterprise and desktop solutions and Ingenuity's pathway analysis software (IPA®), in order to perform both array and next-generation sequencing data and knowledge analyses.
Kaiser Health News provides a fresh take on health policy developments with "To The Moon" by Bob Englehart.
Professor and director of the WHO Collaborating Centre for Obesity Prevention at Deakin University in Australia, examines how "rich countries, ... particularly the U.S. and European Union but also Australia, Canada and New Zealand, ... are joining forces with tobacco, food, alcohol and pharmaceutical corporations to water down commitments that might flow from" this month's U.N. High-level Meeting on Non-Communicable Diseases (NCDs) in New York.
Shire plc, the global specialty biopharmaceutical company, today announced new findings on once-daily INTUNIV (guanfacine) Extended Release Tablets, the first selective alpha-2A agonist approved for the treatment of Attention Deficit Hyperactivity Disorder, at a major psychiatric meeting.
› Verified 9 days ago
Mrs. Darleen Dansby, APN Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 1513 Viceroy Dr, Dallas, TX 75235 Phone: 469-685-7020 Fax: 214-920-7020 | |
Teresa Anna Jones, CPNP-AC Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 1935 Medical District Dr, Dallas, TX 75235 Phone: 973-801-0173 | |
Christina Hagood, NP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 6301 Gaston Ave, Suite 100, West Tower, Dallas, TX 75214 Phone: 214-827-3610 Fax: 214-821-4017 | |
Susan C. Chesire, ANP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 3600 Gaston Ave, Wadley Tower, Suite 651, Dallas, TX 75246 Phone: 214-820-9115 Fax: 214-820-9135 | |
Mrs. Larah Brown, NP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 3209 W Camp Wisdom Rd, Dallas, TX 75237 Phone: 469-966-9660 Fax: 877-667-6112 | |
Michele Willet Rylander, RN, MSN, CPNP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 1935 Medical District Dr, Dallas, TX 75235 Phone: 214-456-7000 |